| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/22/1999 | CA2318231A1 Use of radiolabeled monoclonal igm in therapy for cancer and autoimmune disease |
| 07/22/1999 | CA2316273A1 Sustained-release composition, method of its production and use thereof |
| 07/22/1999 | CA2314148A1 Pharmaceutical formulations and processes for their preparation |
| 07/22/1999 | CA2282583A1 Plasticizer and patch containing the same |
| 07/21/1999 | EP0930077A1 Cyclodextrin compositions comprising an avermectin or a milbemycin derivative |
| 07/21/1999 | EP0930070A1 Stable aspirin ointment preparations |
| 07/21/1999 | EP0930068A2 Trovafloxacin mesylate tablet |
| 07/21/1999 | EP0930066A2 Low tack lotion, gels and creams |
| 07/21/1999 | EP0930060A1 Cosmetic composition without transfer containing a non-filmforming polymer particles dispersion |
| 07/21/1999 | EP0930022A2 Use of carotinoid aggregates as colourants |
| 07/21/1999 | EP0929688A1 Sustained delivery device and methods of making and using the same |
| 07/21/1999 | EP0929536A1 Piperazine based cytofectins |
| 07/21/1999 | EP0929317A2 Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof |
| 07/21/1999 | EP0929314A1 Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form |
| 07/21/1999 | EP0929301A2 Controlled release dosage form of r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2]oct-3-yl)acetonitrile monohydrochloride |
| 07/21/1999 | EP0929293A1 Liposomes containing a cisplatin compound |
| 07/21/1999 | EP0929270A1 Oral peptide pharmaceutical products |
| 07/21/1999 | EP0929234A1 Tablets containing a sweetening mixture |
| 07/21/1999 | EP0929232A1 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
| 07/21/1999 | EP0714411B1 Process for obtaining mucoadhesive starch |
| 07/21/1999 | CN1223658A Halo-substituted protein kinase C inhibitors |
| 07/21/1999 | CN1223591A Micellar aqueous composition and method for solubilizing hydrophobic drug |
| 07/21/1999 | CN1223573A Enteric coating, comprising alginic acid, for an oral preparation |
| 07/21/1999 | CN1223113A Using W/O emulsions as thickeners in cosmetic and pharmaceutical formulations |
| 07/20/1999 | US5925776 Low sodium, potassium, and aluminum cation content; storage stability; exposing to cationic exchange resin |
| 07/20/1999 | US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 07/20/1999 | US5925739 Pharmaceutical formulation for subcutaneous intramuscular or intradermal administration of factor VIII |
| 07/20/1999 | US5925738 Stable aqueous liquid of plasma protein, buffer, calcium ions, and osmotic modulating agent; for treatment of blood disorders by administration of blood coagulation factors |
| 07/20/1999 | US5925720 Heterotelechelic block copolymers and process for producing the same |
| 07/20/1999 | US5925679 Glycol base with azelaic acid and acid ph for skin disorders like acne, hair loss and wrinkling |
| 07/20/1999 | US5925669 Antitumor agents |
| 07/20/1999 | US5925626 Hyaluronic acid fractions having pharmaceutical activity, and pharmaceutical compositions containing the same |
| 07/20/1999 | US5925623 Formulations and methods for generating active cytofectin: polynucleotide transfection complexes |
| 07/20/1999 | US5925619 Formulation for peptide release |
| 07/20/1999 | US5925377 Dietary supplement composition |
| 07/20/1999 | US5925353 Targeted radioimmunotherapy |
| 07/20/1999 | CA2259699A1 Cyclodextrin compositions |
| 07/20/1999 | CA2162919C Rectal compositions |
| 07/20/1999 | CA1340656C Membrane anchor/active compound conjugate, its preparation and its use |
| 07/15/1999 | WO1999034837A1 Stabilization of lipid:dna formulations during nebulization |
| 07/15/1999 | WO1999034833A1 Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom |
| 07/15/1999 | WO1999034832A1 Crystallographically stable amorphous cephalosporin compositions and process for producing the same |
| 07/15/1999 | WO1999034831A1 Enhanced transport using membrane disruptive agents |
| 07/15/1999 | WO1999034830A1 Topical ophthalmic preparations containing immunosuppressive agents |
| 07/15/1999 | WO1999034829A1 Embolizing compositions comprising surfactants |
| 07/15/1999 | WO1999034828A1 A transdermally administered pharmaceutical composition containing astringents |
| 07/15/1999 | WO1999034822A1 Formulations for amylin agonist peptides |
| 07/15/1999 | WO1999034821A1 Stabilised insulin compositions |
| 07/15/1999 | WO1999034809A1 Solid iodophor preparations and process for producing the same |
| 07/15/1999 | WO1999034782A1 Tts containing an antioxidant |
| 07/15/1999 | WO1999034774A1 Topical application of enzymes using a peelable film |
| 07/15/1999 | WO1999034751A1 A drug dosage form based on the teorell-meyer gradient |
| 07/15/1999 | WO1999034680A1 Decorated red blood cells |
| 07/15/1999 | WO1999024391B1 Radio-opaque polymer biomaterials |
| 07/15/1999 | WO1999024070A3 Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field |
| 07/15/1999 | WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 07/15/1999 | DE19803193C1 Use of lecithin and alpha-bisabolol mixtures |
| 07/15/1999 | CA2365742A1 Formulations for amylin agonist peptides |
| 07/15/1999 | CA2317640A1 Decorated red blood cells |
| 07/15/1999 | CA2317587A1 Solid iodophor preparations and process for producing the same |
| 07/15/1999 | CA2317010A1 Topical ophthalmic preparations containing immunosuppressive agents |
| 07/15/1999 | CA2315708A1 Stabilization of lipid:dna formulations during nebulization |
| 07/15/1999 | CA2256793A1 New compound intended by way of oromucous membrane notably pernasal |
| 07/14/1999 | EP0928611A1 Medical powder |
| 07/14/1999 | EP0928301A1 Fluid composition for physiological separations |
| 07/14/1999 | EP0928206A1 A hydrocolloid wound gel |
| 07/14/1999 | EP0928201A1 Novel glycolipid complexes and their uses |
| 07/14/1999 | EP0928196A1 Beta-glucan products and extraction processes from cereals |
| 07/14/1999 | EP0928192A1 Antimycotic gel with high active substance release |
| 07/14/1999 | EP0928190A2 Nucleic acid particle delivery |
| 07/14/1999 | EP0928187A1 Antibacterial composition |
| 07/14/1999 | EP0689422B1 Fluorocarbon emulsions with reduced pulmonary gas-trapping properties |
| 07/14/1999 | CN1222905A New synthetic catechol derivatives, method for production and use thereof |
| 07/14/1999 | CN1222857A Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid |
| 07/14/1999 | CN1222403A Process for manufacture of amorphous products by means of convection drying |
| 07/14/1999 | CN1044093C Low-toxicity medicinal lipid preparation |
| 07/13/1999 | US5922847 Exposure to antibody or fragments binding to epitope on receptor recognized by the factor, separating binding cells |
| 07/13/1999 | US5922765 Methods and compositions for the prevention and treatment of muscle cramps and improving muscular strength |
| 07/13/1999 | US5922754 Pharmaceutical compositions containing paclitaxel |
| 07/13/1999 | US5922729 Water soluble polymer-tacrolimus conjugated compounds and process for preparing the same |
| 07/13/1999 | US5922682 Polyol esters, their preparation and use in depot forms of pharmacologically active agents |
| 07/13/1999 | US5922580 Contacting a reducing partial starch hydrolysate with a novel enzyme which forms a non-reducing saccharide in the absence of trehalose; glucoamylase and glycosidase yield trehalose when allowed to act on the non-reducing saccharide |
| 07/13/1999 | US5922358 Antithrombotic and non-hemorrhagic heparin-based compositions, process for their preparation and therapeutic applications |
| 07/13/1999 | US5922355 Composition and method of preparing microparticles of water-insoluble substances |
| 07/13/1999 | US5922350 Dehydration in presence of sugars present at a protectiveconcentration on both inside and outside surfaces; liposomeshave ion concentration gradient capable of generatingtransmember potential to load charged material |
| 07/13/1999 | US5922338 Polyol esters, their preparation and use in depot forms of pharmacologically active agents |
| 07/13/1999 | US5922313 Lotion consists of a mixture of polyvinylpyrrolidone and hydroxyethyl cellulose, an antibacterial agent chlorhexidine digluconate or 2,4,4'-trichloro-2'-hydroxydiphenylether, blend of glyceryl stearate and polyethylene glycol emulsifer |
| 07/13/1999 | US5922305 Methods of treating tissues with oxygen-supersaturated emulsions |
| 07/13/1999 | US5922304 Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents |
| 07/13/1999 | US5922302 Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 07/13/1999 | US5922253 Production scale method of forming microparticles |
| 07/13/1999 | CA2259098A1 Sustained-release pharmaceutical composition |
| 07/13/1999 | CA2257547A1 Process for producing solid dosage forms |
| 07/13/1999 | CA2256836A1 Lip care composition containing acexamic acid, its uses |
| 07/13/1999 | CA2162249C Cholesterol lowering drink mix compositions |
| 07/13/1999 | CA2157793C Macromolecular microparticles and methods of production |
| 07/13/1999 | CA2121257C Stabilised antibodies |
| 07/08/1999 | WO1999033924A1 Gelatine compositions |
| 07/08/1999 | WO1999033853A2 Carbohydrates, useful in solid delivery systems |
| 07/08/1999 | WO1999033780A1 Novel polyethoxylated castor oil, process of making the same and formulations thereof |